Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study

BACKGROUND: In February 2011, an Ohio law took effect mandating use of the United States Food and Drug Administration (FDA)-approved protocol for mifepristone, which is used with misoprostol for medication abortion. Other state legislatures have passed or enacted similar laws requiring use of the FD...

Descripción completa

Detalles Bibliográficos
Autores principales: Upadhyay, Ushma D., Johns, Nicole E., Combellick, Sarah L., Kohn, Julia E., Keder, Lisa M., Roberts, Sarah C. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004901/
https://www.ncbi.nlm.nih.gov/pubmed/27575488
http://dx.doi.org/10.1371/journal.pmed.1002110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004901/
https://www.ncbi.nlm.nih.gov/pubmed/27575488
http://dx.doi.org/10.1371/journal.pmed.1002110

Ejemplares similares